首页> 外国专利> Use of heptyl glucoside as skin penetration enhancer in transdermal pharmaceutical compositions

Use of heptyl glucoside as skin penetration enhancer in transdermal pharmaceutical compositions

机译:庚基葡萄糖苷在透皮药物组合物中作为皮肤渗透促进剂的用途

摘要

The present disclosure refers to heptyl glucoside included, as a natural solubilizer and as a skin penetration enhancer, in transdermal pharmaceutical compositions. Heptyl glucoside is a natural alkyl glycoside and a hydrotrope that improves solubility of active pharmaceutical ingredients (APIs), thereby enhancing skin permeability to APIs. Transdermal pharmaceutical compositions including heptyl glucoside allow lower APIs dosage requirements. Heptyl glucoside can be combined with at least one API and suitable ingredients to formulate transdermal pharmaceutical compositions with improved skin permeability, thereby promoting percutaneous absorption of APIs. Transdermal pharmaceutical compositions including heptyl glucoside can be formulated in a plurality of dosage forms, such as, a liquid, cream, paste, gel, lotion, patch (e.g., matrix and reservoir), tape, film former (e.g., plaster), and the like.
机译:本公开涉及包含在透皮药物组合物中的作为天然增溶剂和作为皮肤渗透促进剂的庚基葡糖苷。庚基葡糖苷是天然烷基糖苷和水溶助长剂,可改善活性药物成分(API)的溶解度,从而增强皮肤对API的渗透性。包括庚基葡糖苷的透皮药物组合物允许较低的API剂量要求。庚基葡糖苷可以与至少一种API和合适的成分组合以配制具有改善的皮肤渗透性的透皮药物组合物,从而促进API的经皮吸收。包含庚基葡糖苷的经皮药物组合物可以配制成多种剂型,例如液体,乳膏,糊剂,凝胶,洗剂,贴剂(例如基质和储库),胶带,成膜剂(例如膏药)和类似。

著录项

  • 公开/公告号US9750813B2

    专利类型

  • 公开/公告日2017-09-05

    原文格式PDF

  • 申请/专利权人 DANIEL BANOV;

    申请/专利号US201514682419

  • 发明设计人 DANIEL BANOV;

    申请日2015-04-09

  • 分类号A61K31/56;A01N43;A61K47/26;A61K31/565;A61K47/14;A61K9;

  • 国家 US

  • 入库时间 2022-08-21 13:43:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号